<DOC>
	<DOCNO>NCT00237991</DOCNO>
	<brief_summary>GlaxoSmithKline Korea submit registration file hepatitis A vaccine . The present study collect clinical data local target population per requirement Korean Food Drugs administration ( FDA ) .</brief_summary>
	<brief_title>Safety GlaxoSmithKline ( GSK ) Biologicals Hepatitis A Vaccine Korean Population</brief_title>
	<detailed_description>All subject administer one dose hepatitis A vaccine .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<criteria>Inclusion criterion Subjects investigator believe and/or parents/guardians comply requirement protocol ( e.g . reachable phone ) enrol study . Free obvious health problem establish medical history clinical examination enter study . Written inform consent obtain subject/ subject ' parent guardian . Exclusion criterion History allergic disease reaction likely exacerbate component vaccine . Acute disease time enrolment . ( Acute disease define presence moderate severe illness without fever . All vaccine administer person minor illness diarrhea , mild upper respiratory infection without lowgrade febrile illness , i.e. , Oral temperature &lt; 37.5°C ( 99.5°F ) / Axillary temperature &lt; 37.5°C ( 99.5°F ) / Rectal temperature &lt; 38°C ( 100.4°F ) / Tympanic temperature oral set &lt; 37.5°C ( 99.5°F ) / Tympanic temperature rectal set &lt; 38°C ( 100.4°F ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>